Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cells
Cell · 2025
DOI: 10.1016/j.cell.2025.08.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025. Verfasst von Hejia Henry Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins Convergence Institute,…. Hauptthemen laut MEDLINE: Cancer Vaccines, Antigens, Neoplasm, Melanoma, T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins Convergence Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins Convergence Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Elec…
Zitieren
APA
Wang, H. H., & Zaidi, N. (2025). Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cells. Cell. https://doi.org/10.1016/j.cell.2025.08.025
Vancouver
Wang HH, Zaidi N. Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cells. Cell. 2025. doi:10.1016/j.cell.2025.08.025
BibTeX
@article{Wang2025,
author = {Wang, Hejia Henry and Zaidi, Neeha},
title = {Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cells},
journal = {Cell},
year = {2025},
doi = {10.1016/j.cell.2025.08.025}
}
EUVIMED